<DOC>
	<DOCNO>NCT00227422</DOCNO>
	<brief_summary>The purpose study evaluate vaccine produce new process administer single dose least good exist Mencevax™ ACWY vaccine term immunogenicity , safety reactogenicity , healthy subject age 2-30 year .</brief_summary>
	<brief_title>Assess Non-inferiority GSK Biologicals ' Mencevax™ ACWY ( Manufactured New Process ) v Mencevax™ ACWY ( Already Existing Vaccine Market ) When Given Single Dose Subjects Aged 2-30 Yrs</brief_title>
	<detailed_description>`` Randomized study four group receive one follow vaccination regimen : - One 3 lot GSK Biologicals ' Mencevax™ ACWY vaccine manufacture new process ( 3 different group ) - GSK Biologicals ' already exist Mencevax™ ACWY</detailed_description>
	<mesh_term>Meningococcal Infections</mesh_term>
	<criteria>Inclusion criterion : Healthy male female 2 30 year age time vaccination . If subject female , must nonchildbearing potential . If subject female childbearing potential , must abstinent use adequate contraceptive precaution 30 day prior vaccination , negative pregnancy test must agree continue precaution two month vaccination . Exclusion criterion : Use investigational nonregistered product ( drug vaccine ) within 30 day precede administration study vaccine , plan use study period . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug within six month prior vaccine dose . Vaccination meningococcal vaccine within last five year . Planned administration/ administration vaccine foreseen study protocol period start 15 day vaccine administration end 30 day . History known exposure meningococcal serogroup A , C , W135 Y disease contact subject meningococcal disease . Any confirm suspected immunosuppressive immunodeficient condition , base medical history physical examination .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Neisseria meningitidis serogroups A &amp; C disease</keyword>
	<keyword>Hib disease</keyword>
</DOC>